Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Cohen Fredric J., Directeur Médical. Director active across 2 companies, notably Strongbridge Biopharma plc. In total, 2 filings have been logged. History available since 1 October 2021. The latest transaction was filed on 1 October 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Fredric J. Cohen is the Chief Medical Officer of Strongbridge Biopharma plc. He oversees the company's clinical initiatives and product development strategies. With a strong background in the medical field, he plays a crucial role in guiding Strongbridge's research and development efforts.